Neutralization of proANP (1-30) exacerbates hypertension in the spontaneously hypertensive rat
| Autor: | Sook Jeong Lee, Stanley J. Nazian, David L. Vesely, John R. Dietz, William R. Gower, Carol S. Landon |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Male
medicine.medical_specialty Physiology Blood Pressure Endogeny Antibodies Neutralization Spontaneously hypertensive rat Atrial natriuretic peptide Rats Inbred SHR Physiology (medical) Internal medicine Volume expansion Maximum difference medicine Animals Protein Precursors Pharmacology Chemistry Albumin Peptide Fragments Rats Blood pressure Endocrinology Hypertension Atrial Natriuretic Factor |
| Zdroj: | Clinical and Experimental Pharmacology and Physiology. 30:627-631 |
| ISSN: | 1440-1681 0305-1870 |
| DOI: | 10.1046/j.1440-1681.2003.03888.x |
| Popis: | 1. The aim of the present studies was to determine the role of proANP (1-30) in the regulation of arterial pressure. It was hypothesized that blocking endogenous proANP (1-30) would exacerbate the hypertension in susceptible animal models. 2. Pentobarbital-anaesthetized spontaneously hypertensive rats (SHR) were pretreated i.v. with 1.2 mL rabbit serum containing an antibody directed specifically against rat proANP (1-30) (SHR-AB group; n = 7) or an equal volume of normal rabbit serum as a control (SHR-NRS group; n = 5). 3. Following a 1 h equilibration period and two 30 min baseline periods, rats were volume expanded with 3 mL of 6% albumin in Krebs' solution and observed for an additional 3 h to determine the effects of the anti-proANP on arterial pressure. 4. Arterial pressure increased in both groups compared with their own baselines with volume expansion, but was significantly greater in the anti-proANP SHR group compared with the SHR-NRS group throughout the volume expansion period. A maximum difference of 21 mmHg between the anti-proANP SHR group and the NRS-SHR group was observed at 150 min of the study (183 +/- 5 vs 162 +/- 3 mmHg, respectively; P < 0.005. 5. These results suggest a protective role for proANP (1-30) in the SHR model of hypertension. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|